APA (7th ed.) Citation

Longmore, J., Shaw, D., Smith, D., Hopkins, R., McAlliste, G., Pickard, J., . . . Hill, R. (1997). Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia, 17(8), 833. https://doi.org/10.1046/j.1468-2982.1997.1708833.x

Chicago Style (17th ed.) Citation

Longmore, J., D. Shaw, D. Smith, R. Hopkins, G. McAlliste, JD Pickard, DJS Sirinathsinghji, AJ Butler, and RG Hill. "Differential Distribution of 5HT1D- and 5HT1B-immunoreactivity Within the Human Trigemino-cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs." Cephalalgia 17, no. 8 (1997): 833. https://doi.org/10.1046/j.1468-2982.1997.1708833.x.

MLA (9th ed.) Citation

Longmore, J., et al. "Differential Distribution of 5HT1D- and 5HT1B-immunoreactivity Within the Human Trigemino-cerebrovascular System: Implications for the Discovery of New Antimigraine Drugs." Cephalalgia, vol. 17, no. 8, 1997, p. 833, https://doi.org/10.1046/j.1468-2982.1997.1708833.x.